NYON, Switzerland--(BUSINESS WIRE)--A European healthcare consortium (the “Consortium”) of fifteen members comprised of a publicly founded organization, governmental entities, academic teams and biotech companies, including Mymetics Corporation (OTCBB: MYMX; http://www.mymetics.com), was awarded a €7.50 million grant from the European Commission within the context of the European Union’s seventh framework program.
